Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices

NCT00559988 is registered in ClinicalTrials.gov with Biotronik, Inc. as lead sponsor.

NCT NCT00559988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00559988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Lead sponsor
Biotronik, Inc.
Phase
Phase 4
Overall status
Terminated
Start date
February 29, 2008
Completion date
June 30, 2013
Enrollment
2,718 (actual)
Sites
80

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, atrial flutter, embolism, systemic arterial, major bleeding, stroke